Overall market sentiment has been high on Danaher Corporation (DHR) stock lately. DHR receives a Bullish rating from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.
Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.
InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.
For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.
What's Happening With DHR Stock Today?
Danaher Corporation (DHR) stock is lower by -0.78% while the S&P 500 has risen 0.69% as of 11:43 AM on Monday, Oct 19. DHR has fallen -$1.78 from the previous closing price of $227.45 on volume of 818,580 shares. Over the past year the S&P 500 has gained 16.65% while DHR has risen 63.26%. DHR earned $4.68 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 48.22.
To screen for more stocks like Danaher Corporation click here.
More About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which adds to its life sciences segment.
Click Here to get the full Stock Score Report on Danaher Corporation (DHR) Stock.
